NASDAQ:RXST

RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround
····

RxSight stock gains ahead of Stifel meeting, investors wait for signs of turnaround

RxSight shares closed at $6.16 Wednesday, up 3.53% but still down 40.88% in 2026. First-quarter sales fell 18.5% to $30.9 million, with 27,472 Light Adjustable Lens units and 20 Light Delivery Devices sold. Management will speak at the Stifel Virtual Ophthalmology Forum on May 26. The company kept its 2026 sales outlook at $120 million to $135 million.
May 21, 2026

Stock Market Today

  • ASX 200 Poised for Softer Start as Wall Street Hits New Highs
    June 1, 2026, 9:14 PM EDT. The ASX 200 index is expected to open lower following Wall Street's record highs. Global investors remain cautious amid mixed signals in the market. Despite gains in U.S. equities, Australian shares face pressure from sector-specific factors. Market participants are advised to stay informed and exercise due diligence. This report provides a snapshot of early market sentiment with a focus on potential impacts for Australian investors.